Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-02

Clinical Trial Update: Anticoagulants Comparative Benefit-risk Ratio in Real Life

View source ↗

Summary

A completed clinical trial comparing real-life benefit-risk of anticoagulants in atrial fibrillation; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2018-11-02